Ask the Experts. Use of Tissue Plasminogen Activator to Treat Acute Ischemic Stroke
- Intravenous tissue plasminogen activator, ischemic stroke, and the risk of Kounis Syndrome. Kounis, Nicholas G.; Kouni, Sophia N.; Kounis, George N.; Kounis, Sophia A. // Annals of Indian Academy of Neurology;Sep2011, Vol. 14 Issue 3, p223
A letter to the editor is presented in response to the article "Acute Myocardial Infarction Following Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: An Unknown Danger," by A. Sweta et al, in a 2010 issue.
- Hyper acute stroke unit services. DUDLEY, NIGEL // Clinical Medicine;Oct2011, Vol. 11 Issue 5, p508
A letter to the editor is presented in response to an article on hyper acute stroke unit services in June 2011 issue.
- Standard of Care for tPA for Stroke Has Evolved. // ED Legal Letter;Nov2010, Vol. 21 Issue 11, p129
The article describes the evolution of standard of care for tissue plasminogen activator (tPA) for stroke patients. It reveals that the use of tPA in eligible patients had become a public expectation. The article also highlights the views of various emergency medical physicians on the standard...
- A randomised dose ranging study of recombinant tissue plasminogen activator in acute myocardial infarction. McNeill, A.J.; Shannon, J.H.; Cunningham, S.R.; Flannery, D.J.; Campbell, N.P.S.; Khan, M.M.; Patterson, G.C.; Webb, S.W.; Adgey, A.A.J. // British Medical Journal (Clinical Research Edition);6/25/1988, Vol. 296 Issue 6639, p1768
Evaluates a randomized dose ranging study of recombinant tissue plasminogen activator in acute myocardial infarction in Great Britain. Infusion of tissue plasminogen activator intravenously; Improvement in reperfusion rates regardless of dose; Effectiveness of the recombinant tissue plasminogen...
- T-PA OK'd for ischemic stroke; 3 hours after onset is crucial time. // Geriatrics;Aug96, Vol. 51 Issue 8, p23
Reports on the approval of the use of recombinant tissue plasminogen activator (t-PA) as an emergency treatment for ischemic stroke. Reduction of risk of disability; Need for early treatment; Risks.
- Acute stroke therapy: Perspectives on current, future treatments. Lutsep, Helmi L.; Clark, Wayne M. // Formulary;Oct97, Vol. 32 Issue 10, p1040
Focuses on tissue plasminogen activator (t-PA) as an acute stroke therapy. Information on tissue plasminogen activator in stroke; Investigation on thrombolytics and neuroprotective agents.
- Tissue Plasminogen Activator for Acute Ischemic Stroke. // New England Journal of Medicine;12/14/95, Vol. 333 Issue 24, p1581
Background: Thrombolytic therapy for acute ischemic stroke has been approached cautiously because there were high rates of intracerebral hemorrhage in early clinical trials. We performed a randomized, double-blind trial of intravenous recombinant tissue plasminogen activator (t-PA) for ischemic...
- A quick fix for strokes. Gorman, Christine // Time International (South Pacific Edition);9/16/96, Issue 38, p72
Reports on new guidelines issued by the American Heart Association in treating stroke victims. The use of tissue plasminogen activator (TPA) to clear blood clots in the brain; The necessity of performing a CAT scan; The importance of the duration from the stroke's onset; Other treatments used...
- Doctors fail to follow advice in giving tPA. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);03/11/2000, Vol. 320 Issue 7236, p666
Presents studies on tissue-type plasminogen activator (tPA), a drug known for treatment of heart attacks which can improve the recovery of patients who have had strokes. Percentage of deaths associated with tPA; Comments from Gregory Albers, a physician with the Stanford Stroke Center at...